A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries

BACKGROUND: Lotilaner is a novel isoxazoline developed for oral administration to dogs. In laboratory studies, lotilaner was shown to be safe and to produce a rapid flea and tick knockdown, with a sustained speed of kill for at least a month post-treatment. A study was undertaken to demonstrate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalleri, Daniela, Murphy, Martin, Seewald, Wolfgang, Drake, Jason, Nanchen, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664837/
https://www.ncbi.nlm.nih.gov/pubmed/29089065
http://dx.doi.org/10.1186/s13071-017-2479-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664837/
https://www.ncbi.nlm.nih.gov/pubmed/29089065
http://dx.doi.org/10.1186/s13071-017-2479-8

Ejemplares similares